diallyl trisulfide has been researched along with Lymph Node Metastasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Chen, J; Chen, W; Liu, Y; Liu, Z; Lu, Y; Ruan, J; Shan, Y; Sheng, X; Tao, L; Wang, A; Wang, S; Wei, Z; Zhao, Y | 1 |
1 other study(ies) available for diallyl trisulfide and Lymph Node Metastasis
Article | Year |
---|---|
Targeting Thioredoxin System with an Organosulfur Compound, Diallyl Trisulfide (DATS), Attenuates Progression and Metastasis of Triple-Negative Breast Cancer (TNBC).
Topics: Allyl Compounds; Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Disulfides; Female; Humans; Imidazoles; Lymphatic Metastasis; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Protein Binding; RNA Interference; RNA, Small Interfering; Sulfides; Thioredoxins; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2018 |